Physician profile
Kathryn Ray
NPI 1588017743
$1,946.96
in general payments reported to CMS, 2019-2025
17 companies · $577 in 2025
The $577 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.95 · 2023: $396 · 2024: $939 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,912.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,181.48 | 2023-2025 | Farxiga, Wainua, Lokelma |
| Pfizer INC. | $118.22 | 2021-2025 | |
| Amgen INC. | $100.68 | 2023-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $92.43 | 2024-2025 | Verquvo |
| Medicomp INC | $62.10 | 2023-2025 | Telepatch Cardiac Monitor |
| Scpharmaceuticals INC. | $51.23 | 2025 | |
| Novartis Pharmaceuticals Corporation | $51.03 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $43.30 | 2023-2024 | Camzyos |
| Axonics, INC. | $41.87 | 2024 | Axonics |
| Janssen Pharmaceuticals, INC | $34.52 | 2023-2024 | Xarelto |
| Glaxosmithkline, LLC. | $34.13 | 2025 | Shingrix |
| Vital Connect, INC | $29.57 | 2024 | Vitalpatch Rtm |
| Kestra Medical Technology Services, INC. | $28.10 | 2025 | Assure Wcd |
| Melinta Therapeutics, LLC | $24.84 | 2025 | Kimyrsa, Rezzayo |
| Lexicon Pharmaceuticals, INC. | $19.54 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.44 | 2025 | Jardiance |
| Biowound Solutions, INC. | $14.48 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.